Other languages Pacific Shuanglin Bio-pharmacy Co., LTD

Equities

000403

CNE000000F14

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
29.85 ^CNY	+0.54%		+1.26%	+9.58%

Apr. 15	Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4%	MT
Apr. 15	Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4%	Apr. 15
Pacific Shuanglin Bio-pharmacy's Profit Seen More Than Doubling in Q1; Shares Up 3%	Apr. 15
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 12
Pacific Shuanglin Bio-pharmacy Unit Gets Nod to Trial Human Coagulation Factor IX	Nov. 06
Pacific Shuanglin Bio-pharmacy Co., LTD Approves Board Appointments	23-10-26
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-18
Pacific Shuanglin Bio-pharmacy Obtains Another Blood Collection License	23-09-21
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23
Pacific Shuanglin Bio-pharmacy Obtains Blood Plasma Collection License	23-08-08
Pacific Shuanglin Bio-Pharmacy Co., Ltd Announces Final Dividend Implementation on A Shares for the Year 2022, Payable on July 20, 2023	23-07-14
Pacific Shuanglin Bio-pharmacy's Unit Gets Permit to Operate Two Plasma Hubs	23-05-26
Pacific Shuanglin Bio-Pharmacy Co., Ltd Approves 2022 Profit Distribution Plan	23-05-23
Gongqingcheng Shengbang Yinghao Investment Partnership (Limited Partnership) completed the acquisition of 20.99% stake in Pacific Shuanglin Bio-pharmacy Co., LTD from Hangzhou Zhemintou Tianhong Investment Partnership Enterprise (LP) and Zhejiang Private Enterprise United Investment Co., Ltd.	23-05-22
Pacific Shuanglin Bio-pharmacy Registers Blood Clotting Drug	23-05-18
Pacific Shuanglin Bio-pharmacy Signs Drug Supply, Distribution Deal With Brazil’s Hypera Pharma	23-05-05
Pacific Shuanglin Bio-Pharmacy Co., Ltd Announces Final Cash Dividend (Tax Included) for 2022	23-05-04
Pacific Shuanglin Bio-Pharmacy Posts Double-Digit Drop in Q1 Earnings on Lower Sales	23-05-01
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28
Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28
Beijing probes illegal mining activities in Chinese lithium hub - Yicai	23-02-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pacific Shuanglin Bio-pharmacy Co., LTD

Equities

000403

CNE000000F14

Other languages

Filters